✦ LIBER ✦

Multi- analytical approach: better predictor of pharmacogenetic based clinical outcomes in breast cancer therapies

✍ Scribed by Tulsyan, Sonam

Book ID: 121565649
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 81 KB
Volume: 7
Category: Article
ISSN: 1755-8166
DOI: 10.1186/1755-8166-7-S1-P99

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of clinical outcomes in breas

Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach

✍ Tulsyan, Sonam; Chaturvedi, Pankaj; Singh, Abhishek Kumar; Agarwal, Gaurav; Lal, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Pharmacogenetic Influence of GST Polymor

Pharmacogenetic Influence of GST Polymorphisms on Anthracycline-Based Chemotherapy Responses and Toxicity in Breast Cancer Patients: A Multi-Analytical Approach

✍ Tulsyan, Sonam; Chaturvedi, Pankaj; Agarwal, Gaurav; Lal, Punita; Agrawal, Sushm 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 279 KB

Predictive model for the outcome of infl

Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors

✍ Tibor Hlavaty; Marc Ferrante; Liesbet Henckaerts; Marie Pierik; Paul Rutgeerts; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Background: Infliximab (ifx) is an effective therapy for refractory luminal and fistulizing crohn's disease (cd). predictors of response could improve selection of patients with a higher probability of favorable outcomes and could improve the safety profile. we aimed to develop a predictive mode

Significant role of CYP450 genetic varia

Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy

✍ Tulsyan, Sonam; Agarwal, Gaurav; Lal, Punita; Mittal, Balraj 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 548 KB

Time to First Tumor Progression as Outco

Time to First Tumor Progression as Outcome Predictor of a Second Trasuzumab-Based Therapy beyond Progression in HER-2 Positive Metastatic Breast Cancer

✍ Giulio Metro; Diana Giannarelli; Donatello Gemma; Gaetano Lanzetta; Mariangela C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Retrospective Evaluation of Clinical Out

Retrospective Evaluation of Clinical Outcomes in Patients with HER2-Positive Advanced Breast Cancer Progressing on Trastuzumab-Based Therapy in the Pre-Lapatinib Era

✍ Filippo Montemurro; Stefania Redana; Giuseppe Viale; Giuseppina Sanna; Michela D 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 123 KB